Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 3
1963 1
1964 6
1965 3
1966 3
1969 4
1970 6
1972 2
1973 1
1974 1
1976 1
1977 3
1978 2
1990 1
1991 1
1992 2
1994 2
1995 1
1996 2
2005 1
2007 1
2008 2
2009 1
2010 2
2011 3
2012 2
2014 4
2015 7
2016 3
2017 4
2018 7
2019 10
2020 25
2021 30
2022 26
2023 11
Text availability
Article attribute
Article type
Publication date

Search Results

161 results
Results by year
Filters applied: . Clear all
Page 1
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis.
Li Z, Wu Y, Yates ME, Tasdemir N, Bahreini A, Chen J, Levine KM, Priedigkeit NM, Nasrazadani A, Ali S, Buluwela L, Arnesen S, Gertz J, Richer JK, Troness B, El-Ashry D, Zhang Q, Gerratana L, Zhang Y, Cristofanilli M, Montanez MA, Sundd P, Wallace CT, Watkins SC, Fumagalli C, Guerini-Rocco E, Zhu L, Tseng GC, Wagle N, Carroll JS, Jank P, Denkert C, Karsten MM, Blohmer JU, Park BH, Lucas PC, Atkinson JM, Lee AV, Oesterreich S. Li Z, et al. Among authors: fumagalli c. Cancer Res. 2022 Apr 1;82(7):1321-1339. doi: 10.1158/0008-5472.CAN-21-2576. Cancer Res. 2022. PMID: 35078818 Free PMC article.
Breast Cancer Heterogeneity.
Fumagalli C, Barberis M. Fumagalli C, et al. Diagnostics (Basel). 2021 Aug 27;11(9):1555. doi: 10.3390/diagnostics11091555. Diagnostics (Basel). 2021. PMID: 34573897 Free PMC article. Review.
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study.
Fumagalli C, Zocchi C, Tassetti L, Silverii MV, Amato C, Livi L, Giovannoni L, Verrillo F, Bartoloni A, Marcucci R, Lavorini F, Fumagalli S, Ungar A, Olivotto I, Rasero L, Fattirolli F, Marchionni N; AOU Careggi COVID-19 Follow-up study Group. Fumagalli C, et al. Eur J Intern Med. 2022 Mar;97:36-41. doi: 10.1016/j.ejim.2021.11.018. Epub 2021 Dec 7. Eur J Intern Med. 2022. PMID: 34903448 Free PMC article.
Targeted Medical Therapies for Hypertrophic Cardiomyopathy.
Fumagalli C, De Gregorio MG, Zampieri M, Fedele E, Tomberli A, Chiriatti C, Marchi A, Olivotto I. Fumagalli C, et al. Curr Cardiol Rep. 2020 Jan 28;22(2):10. doi: 10.1007/s11886-020-1258-x. Curr Cardiol Rep. 2020. PMID: 31993794 Review.
Bowel-associated dermatosis-arthritis syndrome (BADAS).
Richarz NA, Bielsa I, Morillas V, Enguita V, Fumagalli C. Richarz NA, et al. Among authors: fumagalli c. Australas J Dermatol. 2021 May;62(2):241-242. doi: 10.1111/ajd.13516. Epub 2020 Dec 12. Australas J Dermatol. 2021. PMID: 33314024 No abstract available.
Letter to the Editor.
Fumagalli C, Casadio C, Barberis M, Guarize J, Guerini-Rocco E. Fumagalli C, et al. Clin Lung Cancer. 2018 Jul;19(4):e439-e440. doi: 10.1016/j.cllc.2018.03.001. Epub 2018 Mar 12. Clin Lung Cancer. 2018. PMID: 29606366 Free article. No abstract available.
161 results